Bexorg Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $23M

  • Investors
  • 6

Bexorg General Information

Description

Developer of human-brain drug perfusion technology designed to advance the development of treatments for neurological diseases. The company combines whole-human-brain perfusion technology with AI-driven molecular analysis to evaluate drug exposure, target engagement, and therapeutic responses in human brain tissue, enabling researchers and drug developers to conduct detailed studies of neurological conditions for more precise predictive CNS drug development.

Contact Information

Website
www.bexorg.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 290 Congress Avenue
  • New Haven, CT 06519
  • United States
+1 (203)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 290 Congress Avenue
  • New Haven, CT 06519
  • United States
+1 (203)

Bexorg Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bexorg Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 23-Sep-2025 $23M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Oct-2023 Completed Generating Revenue
To view Bexorg’s complete valuation and funding history, request access »

Bexorg Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A-2
Series A-1 1,772,394 $0.000010 $6.02 $6.02 1x $6.02 9.01%
To view Bexorg’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bexorg Patents

Bexorg Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260354373-A1 Perfusion and metabolic restoration of organs Pending 08-May-2025
WO-2026236029-A1 Perfusion and metabolic restoration of organs Pending 08-May-2025
WO-2026156072-A1 Method of isolating extracellular hemoglobin protein from worms Pending 15-Jan-2025
US-20260200972-A1 Perfusion and metabolic restoration of organs Pending 15-Jan-2025
EP-4837195-A1 Graph-based machine learning for artificial brain perfusion experiments Pending 03-Jan-2025
To view Bexorg’s complete patent history, request access »

Bexorg Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bexorg Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amplify Partners Venture Capital Minority
Connecticut Innovations Venture Capital Minority
E1 Ventures Venture Capital Minority
Starbloom Capital Venture Capital Minority
BluePrint (Asset Management) VC-Backed Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Bexorg FAQs

  • When was Bexorg founded?

    Bexorg was founded in 2021.

  • Where is Bexorg headquartered?

    Bexorg is headquartered in New Haven, CT.

  • What is the size of Bexorg?

    Bexorg has 48 total employees.

  • What industry is Bexorg in?

    Bexorg’s primary industry is Discovery Tools (Healthcare).

  • Is Bexorg a private or public company?

    Bexorg is a Private company.

  • What is the current valuation of Bexorg?

    The current valuation of Bexorg is .

  • What is Bexorg’s current revenue?

    The current revenue for Bexorg is .

  • How much funding has Bexorg raised over time?

    Bexorg has raised $42.5M.

  • Who are Bexorg’s investors?

    Amplify Partners, Connecticut Innovations, E1 Ventures, Starbloom Capital, and BluePrint (Asset Management) are 5 of 6 investors who have invested in Bexorg.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process